Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

Historical Holders from Q2 2024 to Q3 2025

Symbol
CTNM on Nasdaq
CUSIP
21217B100
Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Shares outstanding
21.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
17.5M
Holdings value
$205M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
60
Number of buys
32
Number of sells
-38
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $8.11M 2.12M RA Capital Management, L.P. Jul 18, 2025
FRANKLIN RESOURCES INC 7.7% -13.3% $19.5M -$509K 1.66M -2.55% Franklin Resources, Inc. Sep 30, 2025
SECTORAL ASSET MANAGEMENT INC 4.99% $6.14M 951K Jerome G. Pfund Dec 31, 2024
PERCEPTIVE ADVISORS LLC 3.2% -53.8% $7.03M -$7.45M 699K -51.5% Perceptive Advisors LLC Jun 30, 2025

Institutional Holders of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 17.5M $205M +$48.6M $11.75 60
2025 Q2 13.9M $55.3M -$6.41M $3.97 68
2025 Q1 15.1M $106M -$10.2M $6.98 62
2024 Q4 15.8M $231M +$21.9M $14.65 60
2024 Q3 13.6M $256M +$9.08M $19.14 51
2024 Q2 13M $229M +$229M $17.61 49